| 产品详情 |
| Edit |   |
| Product Name | Dolutegravir Sodium Salt |
| Description | Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. Molecular Formula: C20H18F2N3NaO5 Solubility: DMSO (Slightly, Heated) Molecular Weight: 441.36 |
| Size | 2mg, 2.5mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | 447645 |
| Price | |
| Order / More Info | Dolutegravir Sodium Salt from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|